Dexmedetomidine + Normal Saline
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Spine Surgery
Conditions
Spine Surgery
Trial Timeline
Feb 1, 2008 → May 1, 2010
NCT ID
NCT00494832About Dexmedetomidine + Normal Saline
Dexmedetomidine + Normal Saline is a pre-clinical stage product being developed by Pfizer for Spine Surgery. The current trial status is completed. This product is registered under clinical trial identifier NCT00494832. Target conditions include Spine Surgery.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00494832 | Pre-clinical | Completed |
Competing Products
2 competing products in Spine Surgery
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Sugammadex + Neostigmine + Glycopyrrolate + Rocuronium | Merck | Approved | 85 |
| sugammadex + Neostigmine | Merck | Approved | 85 |